J Biol Chem, Vol. 275, Issue 5, 3681-3686, February 4, 2000

Mutational Analysis of Intrinsic Regions of Presenilin 2 That Determine Its Endoproteolytic Cleavage and Pathological Function^*

Keiro Shirotani^§, Keikichi Takahashi, Wataru Araki, Kei Maruyama^¶, and Takeshi Tabira

From the  Division of Demyelinating Disease and Aging, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502 and the ^¶ Department of Molecular Biology, Tokyo Institute for Psychiatry, Tokyo 156-8585, Japan

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

To investigate the significance of endoproteolytic processing of presenilin 2 (PS2) on its pathological function, we constructed PS2 cDNAs causing amino acid substitutions or deletions around the cleavage site. We found that a PS2 mutant (Del3) with a 20-amino acid deletion was not endoproteolytically processed, while other PS2s with amino acid substitutions and short deletions were cleaved. Overproduction of all the mutant proteins led to a compensatory decrease of endogenous PS1 fragments, but did not affect the amyloid  peptide X-42/A X-40 ratio without the familial Alzheimer's disease mutation. The Del3 mutant did not exhibit significant deficits in -secretase activity. The turnover rate of the Del3 holoprotein was the same as that of full-length PS2. These data suggest that the determinants of the PS2 cleavage site reside within a large region and that the pathological function of PS2 is exerted by familial Alzheimer's disease mutations not related to the cleavage of holoproteins. We also found that PS2 with an 18-amino acid deletion at the C-terminal end was not processed. Its overexpression led neither to diminished accumulation of endogenous PS1 fragments nor to increased production of amyloid  peptide X-42. The C-terminal end of PS2 seems to possess the signal for entry into the processing pathway.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Mutations in homologous presenilin 1 and 2 (PS1¹ and PS2) genes are associated with early-onset autosomal dominant familial Alzheimer's disease (FAD) (1-3). To date, more than 50 different pathogenic missense mutations and one splice site mutation (loss of exon 10, designated as PS1E10) have been found in PS1, and two missense mutations have been identified in PS2. The gene products of PS1 and PS2 are thought to contain six or eight transmembrane (TM) domains, and the N and C termini and a large hydrophilic loop region following the sixth TM domain are located within the cytoplasm (4-6). PS1 proteins are involved in cell fate decisions by facilitating Notch signaling pathway (7-9). Recently, PS1 proteins have been shown to have a role in the endoproteolytic processing of -amyloid precursor protein (APP) (10, 11) and Notch (12-14), and trafficking of proteins including APP (15) and Notch (12, 13), while the physiological function of PS2 proteins is poorly understood. The amount of highly amyloidogenic A42 (amyloid  peptide 42) increases in cells and transgenic mice with the PS1 and PS2 mutant genes (16-20), supporting a hypothesis that mutations in PS lead to Alzheimer's disease by increasing the extracellular levels of A42.

The PS proteins are proteolytically cleaved at the hydrophilic loop region and detected predominantly as N-terminal fragments (NTF) and C-terminal fragments (CTF) in culture cells and tissues (19, 21-23). The formation of PS fragments is highly regulated in a saturable and stoichiometric manner, since overproduction of full-length PS in transfected cells and transgenic mice does not yield a linear increase of fragments (21) and causes a compensatory decrease of the endogenous PS fragments (21, 24, 25). However, the enzyme involved in the normal PS cleavage remains to be determined. The processed fragments form stable heterodimers and occur as a high molecular weight complex, while the remaining full-length proteins are rapidly degraded (20, 23, 25-30). Therefore, it is proposed that these heterodimers consisting of NTF and CTF are functional units of PSs. Interestingly, PS1E10 has a longer half-life than that of full-length PS1, although it does not undergo endoproteolytic processing because of the lack of the cleavage region. In addition, the overexpression of PS1E10 causes a compensatory decrease of endogenous presenilins and it is incorporated into the high molecular weight complex (17, 21, 25, 27, 28). In contrast, exogenous expression of NTF or CTF alone leads to neither diminished accumulation of endogenous presenilin fragments nor increased production of A42, even though they have FAD mutations (31-35). Moreover, the overexpressed NTF is not incorporated into the heterodimer (33, 35). These data indicate that the processing step of full-length PSs, including the stabilization, endoproteolytic cleavage and the formation of the heterodimer, plays a key role in producing pathological forms, although the possibility cannot be excluded that the cleavage of holoprotein is not essential to form functional PSs.

In the present study, we investigated the nature and specificity of the endoproteolytic processing of PS2 and its relation to the pathological function using mutants with amino acid substitutions and deletions around the cleavage site. Our data indicate that the proteolytic cleavage of PS2 at Lys³⁰⁶/Leu³⁰⁷ does not depend on amino acid sequence and that overexpression of any mutant PS2s has no effect on A X-42/A X-40 ratio without the N141I FAD mutation. We also found that the integrity of the C-terminal end of PS2 is a prerequisite for its entry into the processing pathway.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Preparation of Mutant PS2 cDNAs-- The PS2-pCEP4 was constructed by ligation of full-length human PS2 cDNA into the PvuII site of an expression vector pCEP4 (Invitrogen, San Diego, CA), as reported previously (36). Mutations at the cleavage site of PS2 (K306A, K306E, KL/AP, and MAK/3A) were introduced using a site-directed mutagenesis kit (Stratagene, La Jolla, CA). The DNA fragments with these mutations were excised with NotI and HindIII, and ligated into the NotI/HindIII-digested PS2-pCEP4. For constructing Del1, 5' and 3' regions encompassing amino acid residues 46-303 and 310-384 were separately amplified from PS2 cDNAs by PCR using primer pairs 5'-CAGTGGAGAAGCCAGGAGAAC GAGG-3'/5'-CCGGATCCAACCGTCCACACCATGGCAGATG-3' for the 5' region and 5'-CCGGATCCTCTCAGGGTGCCCTCCAGC-3'/5'-TCAGTCCCCGCTGCCCGTGGCAG-3' for the 3' region, respectively. The PCR product was subcloned into the SmaI site of pUC18 and sequenced. The DNA fragments corresponding to the 5' and 3' regions were excised with NotI/BamHI and BamHI/HindIII, respectively, and were ligated into the NotI/HindIII-digested PS2-pCEP4, resulting in Del1 cDNA lacking residues 304-309. Del2 and Del3 were constructed by similar procedures using the primer pairs 5'- CAGTGG AGAAGCCAGGAGAACGAGG -3'/5'-CCGTCGACCATGGCAGATGAGTATAT CAGGGC-3' and 5'-GGCCCGGGGCCCTCCAGCTCCCCTACGACCC-3'/5'-TCAGTCCCCGCTGCCCGTGGCAG-3' for Del2 and 5'-CAGTGGAGAAGCCAGGAGAACGAGG-3'/5'-CCTCGCGATGAGTATATCAGGGAGGGAATAT-3' and 5'-CCCAGCTGCCCTACGACCCGGAGATGGAAGAA-3'/5'-TCAGTCCCCGCTGCCCGTGGCAG-3' for Del3, respectively. After subcloning the PCR products into the pUC18 vector, the 5'- and 3'-DNA fragments were excised with either NotI/HincII and SmaI/HindIII or NotI/Nru I and PvuII/HindIII, and ligated into the NotI/HindIII-digested PS2-pCEP4, resulting in Del2 and Del3 lacking residues 300-312 and 297-316, respectively. PS2HA was constructed as follows; a BglII site was engineered into the 3' end of a coding region of PS2 by PCR amplification of CTF (307-488) using the primer pair 5'-GGGACTAGTGACCATGATTACGAATTCGAGCTC-3'/5'-CCCAGATCTGATGTAGAGCTGATGGGAGGCCA-3' from PS2CTF-pUC18. After cloning of the PCR product into pUC18 (pCTF-BglII), a double-stranded synthetic oligonucleotide (5'-GATCTTACCCATACGACGTCCCAGACTACGCTTAATCT AGAGG-3'/5'-CCTCTAGATTAAGCGTAGTCTGGGACGTCGTATGGGTAA-3') encoding the hemagglutinin epitope sequence (YPYDVPDYA) was ligated into the BglII/HincII-digested pCTF-BglII. The resulting PS2CTFHA-pUC18 was excised with HindIII/XbaI and subcloned into the HindIII/XhoI-digested PS2-pCEP4, resulting in PS2HA-pCEP4. PS2-430 cDNA was prepared by amplification of the CTF encompassing residues 307-430 using the primer pair 5'-CAGGGCTATGCTGGACCCCTCCTCTCAGG-3'/5'-TCACGTGGAGAAGTAAAAGATGAGCC-3'. The cDNA was subcloned into pUC18, excised with HindIII, and ligated into the HindIII-fragment of PS2-pCEP4, resulting in PS2-430 cDNA encoding residues 1-430.

Cell Culture and Transfection-- SH-SY5Y human neuroblastoma cell lines were cultured in DMEM/F-12 medium (Life Technologies, Inc.) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (Life Technologies, Inc.). Stable cell lines were obtained by transfection of corresponding cDNAs into SH-SY5Y cells using the calcium phosphate method and selection with 400 µg/ml hygromycin B (36). COS cells were transiently transfected with sh (37) as a positive control of APPC100.

Antibodies-- The rabbit polyclonal antibodies Ab111 and Ab333 were raised against glutathione S-transferase fusion proteins encompassing residues 271-407 of PS1 and 277-387 of PS2, respectively, and have been characterized previously (36, 38). PS1N62 and PS2N53 were mouse monoclonal antibodies against glutathione S-transferase fusion proteins encompassing residues 1-70 of PS1 and 1-71 of PS2, and showed similar reactivity to that of previously characterized Ab444 and Ab555C antibodies, respectively (36, 38). 6E10 (Senentek, Maryland Heights, MO) is against A 1-17.

Western Blot Analysis-- Cells were lysed in solution A (0.1 M Tris-HCl, pH 7.4, 0.15 M NaCl) containing a protease inhibitor mixture (Roche Molecular Biochemicals) and 1% Triton X-100 for 1 h at 4 °C. Cells were centrifuged at 14,000 rpm for 20 min, and the supernatant was subjected to Western blot analysis (36).

Metabolic Labeling and Immunoprecipitation-- Cells were plated on 6 cm-dishes and incubated in methionine-free DMEM (Life Technologies, Inc.) with 10% dialyzed fetal bovine serum. After 20 min, cells were labeled with 100 µCi/ml [³⁵S]methionine for 1 h and chased for appropriate time in DMEM with 10% fetal bovine serum. Lysates were prepared as described above and precleared with protein G-agarose (Roche Molecular Biochemicals) for 2 h at 4 °C. Supernatants were incubated with 2 µg of PS2N53 antibody and protein G-agarose overnight at 4 °C. Immunoprecipitates were washed three times in a solution A containing 0.1% Triton X-100, and heated at 60 °C for 10 min in a sample buffer and subjected to SDS-PAGE. The gel was dried and analyzed with a BioImaging BAS5000 analyzer (Fuji, Tokyo, Japan).

ELISA-- Cells were plated on 12-well plates and incubated in DMEM/F-12 with 10% fetal bovine serum for 24 h. Culture medium was collected and subjected to BNT77/BA27 and BNT77/BC05 sandwich ELISAs to quantify A X-40 and A X-42, respectively (39, 40).

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Endoproteolytic Processing of PS2 with Cleavage Site Mutations-- To determine the nature and specificity of endoproteolytic cleavage, we constructed two series of PS2 cDNAs with mutations around the cleavage site (Fig. 1). The first series (K306A, K306E, KL/AP, and MAK/3A) had substitutions with either an alanine, a glutamic acid or a proline residue for a lysine residue and its neighbors, since the lysine is suggestive of a possible trypsin-like specificity. The second mutants had deletions (6, 13, and 20 amino acid residues) around the native cleavage site. Expression and cleavage of mutant PS2 proteins were determined in stable cell lines transfected with these cDNAs using antibodies specific for PS2NTF and PS2CTF (PS2N53 and Ab333, respectively). We also monitored levels of NTF and CTF of endogenous PS1 using antibodies of PS1N62 and Ab111 to evaluate the ability of mutant proteins for entry into the processing pathway.

View larger version (30K): [in this window] [in a new window]   Fig. 1.   Amino acid sequence of mutant PS2s. Amino acid residues 295-330 of the PS2 protein are shown. The normal cleavage site (Lys306/Leu307) is indicated by an arrow (36). Amino acid substitutions and deletions are shown by underlined letters and blanks, respectively.

In cells transfected with PS2WT and PS2N141I (referred to as PS2WT and PS2N141I cells), PS2 polypeptides were detected as a 55-kDa band for the full-length protein, a 35-kDa band for PS2NTF, and a 23-kDa band for PS2CTF (Fig. 2 A, top and bottom panels, lanes 2-4). Amounts of these bands increased in PS2WT and PS2N141I cells, as compared with cells transfected with the pCEP4 vector alone (referred to as pCEP4 cells; Fig. 2A, lane 1), while overproduction of exogenous PS2 diminished the levels of endogenous PS1NTF and CTF (Fig. 2B, lanes 2-4), as described previously (34). Similarly, stable cells transfected with the first series of mutant cDNAs (K306A, K306E, KL/AP, and MAK/3A cells) showed increased amounts of the full-length polypeptides, NTF and CTF (Fig. 2A, top and bottom panels, lanes 5-12), and decreased levels of endogenous PS1NTF and CTF (Fig. 2B, lanes 5-12). The sizes of the PS2 fragments were indistinguishable from native fragments, indicating that these mutant PS2s were endoproteolytically cleaved at or near the original cleavage site. Thus, the MAKL sequence around the cleavage site is not a critical determinant for the proteolytic processing.

View larger version (37K): [in this window] [in a new window]   Fig. 2.   Effects of amino acid substitutions (A and B) and deletions (C and D) around the cleavage site of PS2 on proteolytic processing of mutant PS2s and accumulation of endogenous PS1 fragments. Neuroblastoma SH-SY5Y cells were transfected with PS2 cDNAs with mutations leading to amino acid substitutions (A and B) or deletions (C and D). Several stable cell lines for each cDNA were selected as described under "Experimental Procedures." Species of mutant PS2 cDNAs used for transfection are indicated below the bottom panel of A and C, and the letters m and w represent the presence and absence of the N141I FAD mutation in PS2, respectively. A and C, PS2 polypeptides were detected by Western blot analysis using PS2N53 for full-length protein and NTF (top panel) and Ab333 for CTF (bottom panel). B and D, endogenous PS1 fragments were also determined by Western blot using PS1N62 for PS1-NTF and Ab111 for PS1-CTF.

In stable cells expressing the second mutants (Del1-Del3 cells, Fig. 2C, top panel, lanes 3-16), increased amounts of full-length proteins, which migrated slightly faster than full-length PS2 (Fig. 2C, top panel, lane 2), and decreased levels of endogenous PS1 fragments (Fig. 2D) were also observed. The level of endogenous PS2CTF (23 kDa) was decreased in Del2 and Del3 cells (Fig. 2C, bottom panel, lanes 7-16), indicating that processing of endogenous PS2 was diminished. However, amounts and sizes of processed NTFs and CTFs varied among different mutant cells (Fig. 2C, top and bottom panels, lanes 3-16). In the cases of Del3 cell lines, no band corresponding to PS2CTF was found. In contrast, several faint bands with sizes ranging from 35 to 38 kDa were detected by an antibody specific for PS2NTF in three cell lines that expressed full-length proteins more abundantly (Fig. 2C, lanes 12-14). The 38-kDa band may represent a cleaved product by the caspase family, because its level was induced after treatment with staurosporine (not shown), an activator of caspases (41, 42). Other bands are likely to be degrading intermediates by proteasome, since amounts of those bands greatly increased by treatment with lactacystin (data not shown), which is a potent inhibitor of proteasome. Thus, Del3 protein, similar to PS1E10, does not undergo endoproteolytic processing despite its ability to compete with endogenous PS1 and PS2 for the cellular factor(s), which is predicted to be involved in the stabilization and the endoproteolytic cleavage of presenilin holoprotein (24). On the other hand, PS2CTFs in Del1 were detected mainly as doublet bands at 22.5 and 23 kDa, and PS2CTF in Del2 cells was observed as a band with 21.5 kDa, while the sizes of NTFs were not apparently changed. The decreases of molecular weight for Del1 and Del2 CTFs (loss of 0.5 and 1.5 kDa) were roughly consistent with the size of the deletions (6 and 13 amino acids, respectively). It is also noted that similar results were obtained for mutant PS2s with the N141I FAD mutation, indicating that the introduction of the FAD mutation did not affect levels or sizes of NTF and CTF.

A42-promoting Activity of Mutant PS2 Proteins-- We investigated whether amino acid substitutions or deletions would affect the pathological generation of A42. Fig. 3 (A and B) shows the ratio of amyloid  species (A X-42/A X-40) in media from stable cell lines. As described previously (34), the ratio in PS2N141I cells was 8-9 times higher than those in pCEP4 or PS2WT cells (Fig. 3A). This A42-promoting activity was not observed for all mutants with amino acid substitutions or deletions around the cleavage site, unless they harbored the N141I mutation. In contrast, in cases of PS2s with the N141I mutation, levels of A X-42 promotion varied significantly. K306A, K306E, KL/AP, and MAK/3A mutants with the N141I mutation could increase the A X-42/A X-40 ratio as effectively as PS2N141I (Fig. 3A), while Del1, Del2, and Del3 with the FAD mutation showed decreased A42-promoting activity with increasing sizes of deletion (Fig. 3B). As compared with PS2N141I cells, the average of A X-42/A X-40 ratio was 72% for Del1N141I, 46% for Del2N141I, and 36% for Del3N141I. The different A42-promoting activity among PS2 mutants was not due to the expression level of the PS2 holoprotein, since the highest amount of full-length form was detected in Del3N141I cells (Fig. 2C, top panel). These results indicate that the pathological function of PS2 is affected by deletions, but not by amino acid substitutions around the cleavage site.

View larger version (18K): [in this window] [in a new window]   Fig. 3.   Effects of amino acid substitutions (A) and deletions (B-D) around the cleavage site of PS2 on APP processing. A and B, quantitative ELISA analysis was performed to determine the A X-42/A X-40 ratio in media from the stably transfected cells with mutant PS2 cDNAs indicated below the bars. Data are representative of two (A) and three experiments (B) and shown with means ± S.E. Black and white bars indicate values obtained from cell lines expressing mutant PS2 with and without the N141I mutation, respectively. C, levels of total A secreted in media. White bars and hatched bars represent A X-40 and A X-42, respectively. D, levels of APPCTF were analyzed by Western blot using antibody 6E10. In lane 1, APPC100 cDNA was transiently expressed as a positive control.

It has been suggested that PS1 is itself -secretase and mediates the endoproteolytic processing of PS1 (11). To assess whether the uncleaved Del3 mutant had endoproteolytic activity, we analyzed the levels of total A polypeptide and APP C-terminal fragment (C100). Although clonal variability was observed, the total amounts of A secreted from Del3 cells were comparable to those from other cells (Fig. 3C). The accumulation of APPC100 was detected neither in Del3 cells nor in cells expressing processed PS2 including wild type, Del1, and Del2 mutants (Fig. 3D). These results indicate that the deletion in Del3 does not affect -secretase activity.

Turnover of PS2 and Del3-- We compared the stability of full-length PS2 and Del3, since PS1E10 has been reported to show a longer half-life than full-length PS1 (25, 27). PS2N141I and Del3N141I cells were labeled for 1 h and chased for up to 20 h, followed by immunoprecipitation with the PS2N53 antibody. Full-length PS2 was detected as broad 55-kDa bands in PS2N141I cells and declined with a half-life of 2.11 ± 0.470 h (Fig. 4, left). In the case of Del3, a holoprotein with slightly faster migration also decreased immediately with a half-life of 2.26 ± 0.0147 h (Fig. 4, right). Thus, there is no significant difference in the turnover rate of holoprotein between PS2N141I and Del3N141I. The 35-kDa PS2NTF was detected after a 2-h chase in PS2N141I cells and increased substantially after almost all holoprotein had been catabolized. This result indicates that only a small part of the full-length protein was metabolized into the fragments and the remainder was rapidly degraded. In contrast, processed fragments were not detected in Del3N141I cells during the chase time.

View larger version (50K): [in this window] [in a new window]   Fig. 4.   Pulse-chase analysis of the PS2 protein in stably transfected cell lines with PS2N141I and Del3N141I cDNAs. Stable cells were labeled with [35S]methionine and chased for the indicated time. PS2 proteins were immunoprecipitated with PS2N53 antibody, subjected to SDS-PAGE, and detected using a BioImaging BAS5000 analyzer. Full-length PS2 proteins migrated as relatively broad bands. Bands corresponding to PS2NTF are indicated by an arrowhead.

PS2 Processing Requires Its Integrity of the C-terminal End-- In the course of our study on PS2 processing, we noticed that tagging of influenza virus hemagglutinin at the C terminus of PS2 cDNA caused complete abolishment of endoproteolytic cleavage (data not shown), suggesting that the significance of the C-terminal end on PS2 processing. Therefore, we constructed a mutant (PS2-430) with an 18 amino acid deletion from the C-terminal end. The complete abolishment of endoproteolytic processing was observed in stable cells expressing the mutant PS2 (PS2-430 cells). Although increased levels of full-length PS2-430 were detected as a band with slightly lower molecular weight than full-length PS2 (Fig. 5A, top panel), there was no difference in patterns and intensities of bands corresponding to PS2NTF and PS2CTF between the pCEP4 and PS2-430 cell lines (Fig. 5A, top and bottom panels). The PS2CTF derived from PS2-430 should be detected as a band with faster migration than endogenous PS2CTF. This result also suggested that endoproteolytic processing of endogenous PS2 was not altered in PS2-430 cells. Furthermore, expression of PS2-430 affected neither levels of endogenous PS1 (Fig. 5B) nor levels of the A X-42/A X-40 ratio, even if they harbored N141I (Fig. 5C). These results suggest that the integrity of the PS2 C-terminal end is a prerequisite for entry into the processing pathway.

View larger version (21K): [in this window] [in a new window]   Fig. 5.   Endoproteolytic cleavage of PS2 (A), accumulation of endogenous PS1 fragments (B), and A42-promoting activity (C) in stable cell lines expressing PS2-430. Stable cell lines were prepared using PS2-430 cDNAs as described under "Experimental Procedures." PS2-430 proteins had an 18-amino acid deletion at the C-terminal end of PS2. Species of cDNAs used for transfection are indicated below the bottom panel of A, and other nomenclatures are the same as those in Fig. 1. A, full-length and NTF of PS2 were determined by PS2N53 (top panel), and PS2CTF was determined by Ab333 (bottom panel). B, samples were also subjected to Western blot analysis using PS1N62 for PS1NTF (top panel) and Ab111 for PS1CTF (bottom panels). C, the A X-42/A X-40 ratio was quantified in media prepared from PS2-430 cells with or without the N141I mutation.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

In the present study, we have demonstrated that the endoproteolytic cleavage of PS2 is prevented by a large (20-amino acid) deletion, but not by amino acid substitutions or short (up to 13-amino acid) deletions around the native cleavage site. Furthermore, the integrity of the PS2 C-terminal end is critical for targeting the holoprotein into the processing step, which is thought to include stabilization, cleavage, and formation of the heterodimer of PS2NTF and CTF.

We have previously reported that PS2 is endoproteolytically processed between Lys³⁰⁶ and Leu³⁰⁷ (36). Although the lysine has a possible trypsin-like specificity, the cleavage is not affected by substitutions of a lysine with a glutamic acid or an alanine residue with different charge and conformational structure. In addition, two other stable cell lines expressing mutated proteins with substitutions around this lysine residue (KL/AP and MAK/3A cells) showed a similar processing pattern to the lines expressing wild type PS2, indicating that the endoproteolytic cleavage of PS2 at Lys³⁰⁶/Leu³⁰⁷ is not mediated by proteinase(s) with strict sequence specificity, such as trypsin-type proteinases. In cases of deletion mutants, the endoproteolytic cleavage was found for Del1 and Del2, but not for Del3, although they all lacked the amino acid sequences of the cleavage site. The 22.5- and 21.5-kDa CTF in Del1 and Del2 cells, respectively, corresponded approximately to the deleted sizes, while the sizes of NTF were not apparently changed. On the other hand, the 23-kDa CTF in Del1 cells probably represents a cleaved product at the upstream site with a weaker susceptibility, which might be activated by deletion of the native site. Therefore, it is likely that holoproteins of Del1 and Del2 are cleaved at positions close to the normal cleavage site (approximately the 306th residue from the N-terminal end). On the other hand, the fact that Del3 with 20 amino acid deletion was not processed indicates that the significant determinant of PS2 processing site resides between Ala²⁹⁷ and Val²⁹⁹. This region may be a binding site of the processing enzyme of PS2 or may contribute to the conformational feature around the native cleavage site, which is susceptible to the enzyme. It can be explained by another possibility that the primary cleavage of PS2 takes place upstream (between Ala²⁹⁷ and Val²⁹⁹ of PS2) and is followed by an additional endoproteolytic cleavage at Lys³⁰⁶/Leu³⁰⁷, since cleavage of PS1 occurs not only at Met²⁹⁸ but also at Thr²⁹¹ and Met²⁹² (26) and the amino acid sequence at the upstream site of PS1 is conserved in PS2. To investigate these two possibilities, an additional study will be needed to sequence the C-terminal amino acid of PS2NTF and/or introduce a small deletion and point mutations between Ala²⁹⁷ and Val²⁹⁹ of PS2. It is surprising that an amino acid substitution of either of two transmembrane aspartate residues in PS1 (Asp²⁵⁷ and Asp³⁸⁵ in the sixth and seventh TM domain, respectively) prevented endoproteolytic processing of PS1 (11). This may be due to a greatly altered structure between the sixth and seventh TM domains caused by the aspartate mutation, so that the processing enzyme of PS cannot recognize the cleavage site. Alternatively, the aspartate mutation may block autoproteolysis of PS1 by its intrinsic putative aspartyl protease function. However, the species of the putative presenilinase is still unknown, since any protease inhibitors tested did not block the formation of normally processed PS fragments (23, 33, 43). Recently, proteasome has been reported to be involved partially in the endoproteolytic cleavage of PS1 (44).

The intriguing finding in the present study is that Del3 without the N141I FAD mutation did not affect the production of A42 species, which is in contrast to PS1E10 (17), although neither proteins underwent endoproteolytic processing and their overexpression led to diminished accumulation of endogenous presenilin NTFs and CTFs. PS1E10 identified in FAD patients (45, 46) is caused by a splice site mutation, which removes the whole sequence of exon 10 from PS1 (amino acid residue 291-319) and substitutes cysteine for serine at position 290. Therefore, the question arises whether the A42-promoting activity of PS1E10 is acquired by the 29-amino acid deletion or by the amino acid substitution. The fact that only Del3 with the N141I FAD mutation showed A42-promoting activity suggests that the pathological function of PS1E10 is ascribed to the Ser²⁹⁰  Cys missense mutation, but not to deletion around the cleavage site. In fact, a recent report has shown that a PS1E10 without the missense mutation has no A42-promoting activity (47). Nevertheless, there are still two differences between Del3 with the N141I mutation and PS1E10. First, the former (Del3N141I) was rapidly degraded with the same half-life as PS2N141I, while the latter has a longer half-life than the PS1 holoprotein (25, 27). Second, Del3N141I had the lowest A42-promoting activity among the other PS2 mutants, in contrast to PS1E10, which has similar or higher A42-promoting activity among different FAD PS1 mutants (17, 48, 49). Possible explanations are that exon 10 of PS1 may have an inhibitory effect against the stabilization of a holoprotein or Del3 holoprotein is not stabilized so that its faster degradation gives rise to decreased A42-promoting activity. It is also conceivable that the region around the cleavage site of PS2 is essential to the pathological function, since production of the A42 species declined with increasing sizes of deletion.

Recent observations have suggested that PS1 is itself -secretase and involved in autoproteolysis (11). The fact that the uncleaved Del3 mutant in this study exhibited normal A production indicates that PS2 endoproteolysis is not required for -secretase activity, even if the processing of PS2 is mediated by its autoproteolysis pathway. Moreover, since endogenous PS1 was markedly decreased in Del3 cells (Fig. 2D), the production of A does not necessarily correlate with the function of PS1.

The processing step of PSs, including stabilization, endoproteolytic cleavage, and probably formation of the heterodimer, is thought to be a key step for their pathological functions. Our observations on PS2-430 indicate that the sequence proximal to the C-terminal end is an intrinsic determinant for targeting holoproteins into the processing pathway, which is consistent with previous reports (24, 50). However, it is unexpected that PS2HA failed to undergo endoproteolytic cleavage. A possible explanation for the inability of PS2-430 and PS2HA for entry into the processing pathway is that modifications at the C-terminal end destroys a conformational structure specific for interaction with the putative cellular factor which regulates the processing of PSs (24). In addition, it cannot be ruled out that the putative cellular factor recognizes a specific amino acid sequence rather than a conformation at the C-terminal end. Nonetheless, the region proximal to the PS2 C-terminal end is a critical determinant for conferring susceptibility to endoproteolytic processing and for the pathological function of PS2. Thus, identification of the putative cellular factor(s) that may be associated with the C-terminal end of PSs will give us an insight into understanding the pathogenesis of Alzheimer's disease.

	ACKNOWLEDGEMENTS

We thank Dr. Shoichi Ishiura (University of Tokyo, Tokyo, Japan) for helpful discussion and Tomiko Mano for maintenance of stable cell lines.

	FOOTNOTES

^* This work was supported by a grant (CoE) from the Science and Technology Agency and grants from the Ministry of Health and Welfare of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^§ To whom correspondence should be addressed: Laboratory for Proteolytic Neuroscience, Brain Science Inst. RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan. Tel.: 81-48-462-1111; Fax: 81-48-467-9716; E-mail: kshiro@brain.riken.go.jp.

	ABBREVIATIONS

The abbreviations used are: PS, presenilin; FAD, familial Alzheimer's disease; TM, transmembrane; APP, -amyloid precursor protein; A, amyloid  peptide; NTF, N-terminal fragment; CTF, C-terminal fragment; PCR, polymerase chain reaction; DMEM, Dulbecco's modified essential medium; PAGE, polyacrylamide gel electrophoresis; ELISA, enzyme-linked immunosorbent assay; WT, wild type.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES